Skip to main content
Toggle navigation
Login
Search
Home
Tweets by ASCPT 2022 Annual Meeting
Back
Favorite
Tweet this
Print
Robert C. Penland, PhD
Senior Group Director, Clinical Pharmacology & Pharmacometrics
AstraZeneca
Poster(s):
P-132 - EXENATIDE ONCE-WEEKLY (EQW) PHARMACOKINETICS AND HbA1c EXPOSURE RESPONSE ARE SIMILAR BETWEEN ADOLESCENT PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) AND ADULTS WITH T2DM.